August 3, 2011
Asahi Kasei Corp.
Kuraray Co., Ltd.
Transfer of Asahi Kasei Kuraray Medical shares held by Kuraray
Asahi Kasei and Kuraray has today concluded a share transfer agreement under which Asahi Kasei will receive all the shares held by Kuraray in Asahi Kasei Kuraray Medical Co., Ltd., a joint-venture company which has been operated by the two companies since the integration of their dialyzers businesses in 2007.
Transfer of the shares
1) Shareholding ratio
Before transfer: Asahi Kasei 93%, Kuraray 7%
After transfer: Asahi Kasei 100%
2) Date of transfer:
April 1, 2012
Forthcoming managerial actions
Upon completion of the transfer of the shares held by Kuraray, Asahi Kasei Kuraray Medical Co., Ltd. will become a wholly owned subsidiary of Asahi Kasei Corp. Study on the optimal configuration to further strengthen medical devices-related operations is now to be advanced.
The company name Asahi Kasei Kuraray Medical will be changed without delay following the share transfer.
Corporate profile of Asahi Kasei Kuraray Medical
| President: | Yutaka Shibata |
|---|---|
| Head office: | Tokyo, Japan |
| Paid-in capital: | ¥800 million (as of March 31, 2011) |
| Shareholding ratio: | Asahi Kasei 93%, Kuraray 7% |
| Business line: | Production and sale of APS™ polysulfone-membrane artificial kidneys (dialyzers), Cellsorba™ leukocyte adsorption columns, and other medical devices |
| Production sites: | Oita, Japan; and Nobeoka, Miyazaki, Japan |
* This press release was issued by Asahi Kasei Corporation and Kuraray Co., Ltd.
